Granite Point Capital Management, L.P. Wave Life Sciences Ltd. Transaction History

Granite Point Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 15, 2018	SELL	$32.45 - $54.7 $973,500 - $1.64 Million	-30,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $491,999 - $751,500	30,000	30,000 $653,000

134

72.1M

86.1K

20.1K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $507M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.